PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Provectus Biopharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2010 to Q3 2024.
  • Provectus Biopharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 420M shares, a 0.18% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 420M +758K +0.18% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 420M +25K +0.01% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 420M +25K +0.01% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 419M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 420M +25K +0.01% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 419M +50K +0.01% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 419M +50K +0.01% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 419M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 419M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 419M +15.7M +3.88% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 419M +15.9M +3.94% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 419M +20.6M +5.18% Dec 31, 2021 10-K 2023-03-30
Q2 2021 404M +13.1M +3.35% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 404M +12.9M +3.29% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 399M +8.92M +2.29% Dec 31, 2020 10-K 2022-03-29
Q3 2020 397M +8.28M +2.13% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 391M +5.81M +1.51% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 391M +5.97M +1.55% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 390M +5.27M +1.37% Dec 31, 2019 10-K 2021-03-02
Q3 2019 389M +5.08M +1.32% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 385M +1.8M +0.47% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 385M +5.83M +1.54% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 385M +13.7M +3.68% Dec 31, 2018 10-K 2020-03-05
Q3 2018 384M +12.8M +3.44% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 383M +12.8M +3.44% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 379M +8.53M +2.3% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 371M +6.19M +1.7% Dec 31, 2017 10-K 2019-03-07
Q3 2017 371M +127M +52% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 370M +158M +74% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 370M +158M +74% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 365M +160M +78% Dec 31, 2016 10-K 2018-03-23
Q3 2016 244M +39.3M +19.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 213M +8.27M +4.04% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 213M +26.9M +14.4% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 205M +20.2M +10.9% Dec 31, 2015 10-K 2017-03-31
Q3 2015 205M +24.3M +13.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 205M +27.9M +15.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 186M +12.8M +7.42% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 185M +25M +15.7% Dec 31, 2014 10-K 2016-03-30
Q3 2014 180M +40.3M +28.8% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 177M +48M +37.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 173M +48.6M +39% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 160M +41.3M +34.9% Dec 31, 2013 10-K 2015-03-12
Q3 2013 140M +26.3M +23.1% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 129M +15.7M +13.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 125M +13.6M +12.3% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 118M +7.83M +7.08% Dec 31, 2012 10-K 2014-03-13
Q3 2012 114M +4.06M +3.7% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 113M +4.27M +3.93% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 111M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 111M +109M +5298% Dec 31, 2011 10-K 2013-03-14
Q3 2011 110M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 109M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 2.05M Dec 31, 2010 10-K 2013-03-14
Q1 2010 45.8K* Mar 31, 2010 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.